Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequence requirements for oligodeoxyribonucleotide inhibitory activity.

Robert F Ashman1, J Adam Goeken, Jennifer Drahos

  • 1Department of Internal Medicine, Division of Rheumatology, University of Iowa, 200 Hawkins Drive C31 GH, Iowa City, IA 52242, USA. robert-ashman@uiowa.edu

International Immunology
|March 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Equity Concerns in People with Sickle Cell Disease and Recurrent Vaso-Occlusive Crises: Results from an International Survey Study.

Drugs - real world outcomes·2025
Same author

Clinical burden and healthcare resource utilization of patients with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta-thalassemia in The Netherlands.

Current medical research and opinion·2025
Same author

Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder Cancer.

The American journal of case reports·2025
Same author

Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS).

Biomedicines·2025
Same author

Clinical Images: Destructive sarcoid arthropathy of the small joints.

ACR open rheumatology·2025
Same author

Health-related quality of life and economic impacts in adults with transfusion-dependent β-thalassemia: findings from a prospective longitudinal real-world study.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2025
Same journal

Thymic cortical epithelial Psmb11-encoded β5t in mouse and human.

International immunology·2026
Same journal

Signaling and Transcriptional Control of Thymocyte Differentiation.

International immunology·2026
Same journal

17,18-epoxyeicosatetraenoic acid and its metabolite attenuate IL-33-induced airway inflammation involving group 2 innate lymphoid cells.

International immunology·2026
Same journal

FcμR enhances recall responses by promoting the generation of CD80+PD-L2+ memory B cells.

International immunology·2026
Same journal

Mitochondrial Transfer-Driven Immune Evasion in the Tumor Microenvironment.

International immunology·2026
Same journal

Granulocyte heterogeneity in immune-mediated and inflammatory diseases: Insights from single-cell transcriptomic analyses.

International immunology·2026
See all related articles

Inhibitory oligonucleotides (IN-ODN) can block immune responses triggered by stimulatory CpG ODN (ST-ODN). This study identified key DNA sequence requirements for effective IN-ODN, paving the way for new treatments against overactive immune reactions.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oligonucleotide Therapeutics

Background:

  • Stimulatory CpG oligonucleotides (ST-ODN) activate immune cells, leading to proliferation, cytokine secretion, and protection from apoptosis.
  • Inhibitory oligonucleotides (IN-ODN) can counteract these ST-ODN effects, but their precise sequence requirements were not fully understood.

Purpose of the Study:

  • To determine the specific DNA sequence characteristics of IN-ODN critical for inhibiting immune responses in mice.
  • To define optimal IN-ODN sequences for potential therapeutic applications.

Main Methods:

  • Systematic modification of a prototype inhibitory 15-mer phosphorothioate sequence by altering single bases.
  • Testing the inhibitory activity of modified sequences on B cell proliferation, apoptosis, IL-6 secretion, and IL-12p40 production.

Related Experiment Videos

  • Competitive inhibition assays to understand the mechanism of ST-ODN blockade.

    • Main Results:

    • Identified three critical regions within the IN-ODN sequence essential for inhibitory activity.
    • Demonstrated that spacer sequence length, but not base composition, is important between critical regions.
    • Determined that minor truncations at the 5' and 3' ends are tolerated, leading to an optimized IN-ODN sequence.
    • Showed similar sequence requirements for inhibiting different types of ST-ODN responses.

    Conclusions:

    • Defined the sequence requirements for potent IN-ODN activity, enabling the design of synthetic IN-ODN.
    • Proposed a hypothetical model for the ODN-binding site involved in immune modulation.
    • Highlighted the potential of rationally designed IN-ODN as antidotes for excessive innate immune reactions to DNA.